Clinical Trial Update: Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 neoadjuvant targeted therapy trial in non-small cell lung cancer with disease-free survival as the endpoint; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: 2-year Disease-Free Survival | Phase 3 | Status: UNKNOWN